SCHEMBL19921185

SCHEMBL19921185

COC(=O)c1ccccc1Oc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2OC)nc2ccn(C)c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 5/20 0.59
▸ ALK Q9UM73 13/20 0.56
▸ INSR P06213 11/20 0.56
▸ IGF1R P08069 11/20 0.56
▸ MAPK7 Q13164 1/20 0.52
▸ LRRK2 Q5S007 1/20 0.52
▸ EGFR P00533 2/20 0.51
▸ BMPR1B O00238 1/20 0.51
▸ PLK4 O00444 1/20 0.51
▸ GAK O14976 1/20 0.51
▸ ERN1 O75460 1/20 0.51
▸ STK10 O94804 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ FYN P06241 1/20 0.51
▸ NPM1 P06748 1/20 0.51
▸ FES P07332 1/20 0.51
▸ YES1 P07947 1/20 0.51
▸ HCK P08631 1/20 0.51
▸ ROS1 P08922 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19921139 0.94 EGFR (0.56) PTK2EGFR
SCHEMBL19921168 0.89 ALK (0.65) PTK2ALKINSRIGF1RLRRK2
SCHEMBL19921118 0.87 ALK (0.62) PTK2ALKINSRIGF1RMAPK7
SCHEMBL19921124 0.82 ALK (0.56) PTK2ALKINSRIGF1REGFR
SCHEMBL19921170 0.82 EGFR (0.55) PTK2ALKLRRK2EGFR
SCHEMBL19921145 0.80 DCLK1 (0.43) PTK2LRRK2EGFRFLT3TNK2
SCHEMBL21099882 0.79 ALK (0.66) PTK2ALKINSRIGF1RLRRK2
SCHEMBL19921184 0.79 ALK (0.74) PTK2ALKINSRIGF1RMAPK7
SCHEMBL19921137 0.79 ALK (0.62) PTK2ALKINSRIGF1RMAPK7
SCHEMBL19921155 0.79 EGFR (0.74) PTK2ALKINSRIGF1RMAPK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290420-B1 PYRIMIDINE PYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF UNIV XIAMEN (CN) 2020-12-09 — — EP claimed
US-20180312508-A1 PYRIMIDOPYRROLE COMPOUNDS, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF XIAMEN UNIVERSITY (CN) 2018-11-01 — — US claimed
EP-3290420-A1 PYRIMIDINE PYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF Xiamen University (CN) 2018-03-07 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312508-A1 PYRIMIDOPYRROLE COMPOUNDS, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF TPMT, DHPS, TYMP PTK2 4325/4885ALK 1505/4885INSR 3191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback